Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMB5 is a catalytic component of the 20S core proteasome complex. It exhibits chymotrypsin-like activity and is responsible for the ATP/ubiquitin-dependent degradation of most intracellular proteins. It participates in both ubiquitin-dependent and ubiquitin-independent protein degradation pathways and plays a crucial role in cell cycle regulation, apoptosis, DNA repair, and antigen processing.
Inhibition of chymotrypsin-like activity of the proteasome
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 20S Proteasome Subunit Beta Type-5 (PSMB5).